News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
198 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Neogen reports fiscal 2018 results
Revenues for the entire fiscal 2018 increased 11% to $402,252,000 from the prior year’s $361,594,000
July 17, 2018
·
12 min read
Biotech Beach
AIVITA Biomedical Receives $1.7 million CIRM Grant to Treat Vision Loss
The Company’s ROOT OF SIGHT technology uses three-dimensional retina sheets created from human stem cells, transplanted into the back of the eye, to replace lost retina and improve visual acuity.
July 17, 2018
·
2 min read
BioMidwest
MarketLab Introduces CLIA-Waived Tests to Health Care Supply Network
MarketLab announced that it has expanded its product portfolio to include hundreds of new CLIA-waived testing supplies to address an underserved need in the health care marketplace.
July 17, 2018
·
1 min read
Pharm Country
ECRI Institute to Continue Clinical Guideline Work Shuttered by Federal Government
Former contractor of AHRQ’s National Guideline Clearinghouse will provide healthcare professionals with trusted information
July 17, 2018
·
3 min read
Job Trends
Multi-Store Independent Pharmacy Streamlines Operations with Epicor Eagle N Series Technology
SaluMed Pharmacy focuses on multi-store integration, customer centricity, reducing pricing and inventory errors, and improving business reporting
July 17, 2018
·
3 min read
Drug Development
Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia
Inflection Biosciences Ltd announced the publication of preclinical data showing the company’s dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukaemia (CLL).
July 17, 2018
·
2 min read
Biotech Beach
Irvine Scientific Introduces Chemically-Defined Natural Killer Cell Expansion Medium for Immunotherapy & Translational Research Applications
The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells
July 17, 2018
·
3 min read
Policy
CMA to premiers: Federal funding needed to meet seniors’ care needs
New analysis reveals that provinces and territories will grapple with $93 billion in new health care costs caring for our aging population in the next decade
July 17, 2018
·
2 min read
Policy
BAROnova Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the TransPyloric Shuttle® (TPS®) Device Intended for the Treatment of Obesity
BAROnova, Inc., announced that it has submitted a Pre-Market Approval (PMA) application for the TransPyloric Shuttle device intended for the treatment of obesity to the Food and Drug Administration (FDA).
July 17, 2018
·
3 min read
Deals
H.I.G. Capital Signs Definitive Agreement for the Sale of AMPAC Fine Chemicals
H.I.G. Capital is pleased to announce the signing of a definitive agreement for the sale of its portfolio company AMPAC Fine Chemicals (“AFC” or the “Company”) to SK Holdings Co. Ltd.
July 17, 2018
·
4 min read
Previous
10 of 20
Next